about
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxinGlobally distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic macrolide, mycolactone FEvolution of Mycobacterium ulcerans and other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitorCytokine responses to stimulation of whole blood from patients with Buruli ulcer disease in Ghana.Common evolutionary origin for the unstable virulence plasmid pMUM found in geographically diverse strains of Mycobacterium ulceransSynthesis and structure assignment of the minor metabolite arising from the frog pathogen Mycobacterium liflandii.Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection.Genetic diversity in Mycobacterium ulcerans isolates from Ghana revealed by a newly identified locus containing a variable number of tandem repeatsIn vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans.Genetic diversity of Staphylococcus aureus in Buruli ulcer.Clinical efficacy of Rifampicin and Streptomycin in combination against Mycobacterium ulcerans infection: a systematic review.Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samplesGenetic Susceptibility and Predictors of Paradoxical Reactions in Buruli UlcerCHEMICAL AND MINERALOGICAL CHARACTERISTICS OF FRENCH GREEN CLAYS USED FOR HEALING.Highly stereoselective total synthesis of fully hydroxy-protected mycolactones A and B and their stereoisomerization upon deprotectionMycobacterium ulcerans infection: evolution in clinical management.Pathogenesis of skin ulcers: lessons from the Mycobacterium ulcerans and Leishmania spp. pathogens.Mycobacterium ulcerans mycolactone interferes with adhesion, migration and proliferation of primary human keratinocytes and HaCaT cell line.Paradoxical responses after start of antimicrobial treatment in Mycobacterium ulcerans infection.Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection.Differences in virulence and immune response induced in a murine model by isolates of Mycobacterium ulcerans from different geographic areas.Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism.Associations between Mycobacterium ulcerans and aquatic plant communities of West Africa: implications for Buruli ulcer disease.Apoptosis in Buruli ulcer: a clinicopathological study of 45 cases.Buruli ulcer. Review of a neglected skin mycobacterial disease.A Diverted Total Synthesis of Mycolactone Analogues: An Insight into Buruli Ulcer Toxins
P2860
Q24186073-BD7B24D5-2F3E-4D22-A550-0A23F92505CCQ24524154-B9AA3831-1DE3-410F-8738-DF0D22CEB99BQ24673638-70FD7F3E-90F5-43BC-B34B-65D8B955ED37Q24680677-7CFFB852-638A-4DD8-B4F5-197B00263FDBQ33593952-CA267FC2-DBDE-4C93-88D3-82E53D4489CEQ33714520-D9C1D134-3538-437E-BAB5-0C7B2248CD23Q33733563-C337DB98-CFA0-4A30-B313-F14469AABED0Q34108761-5C957A3D-2315-41D2-845D-CA66E3DB03FBQ34353849-882090AD-E9FE-47B9-A0EC-0CC1EDE0791FQ34680628-F2A7EB32-8B33-4824-90F9-DB1EBBB8287AQ35058098-A1F60409-3EF9-43CB-A9E7-78CC5A88E9E6Q35084312-C5B5FDF7-9F48-42C2-88A8-4AB6624B562BQ35946813-5054D216-6071-45AF-88A3-13E2EB5C33F4Q35994923-E061184F-A15A-4654-8BDC-4F39869BA22DQ37010094-1971282A-B8C2-4F90-AB2C-F381F7D058A4Q37296425-F8D82D66-9ECA-412E-8A03-00B896BB4139Q38044475-D7183F94-15AC-4826-9CE8-041C18F202ACQ38180374-2ABA1A5F-7B48-4262-85CD-C0A86D873C2EQ38715292-28A2381E-659B-4781-B940-77261E3E9E97Q40011360-E9338026-D2FF-4465-B2AC-6377474A3361Q42205104-B807B9E4-89A0-4427-A950-CCD61F6E74A4Q45928623-04CC548E-6E34-4BD1-8FE7-C6890C086A3CQ46201652-C3F2E00A-EBF0-48CB-9CA9-F2CE37E75F5DQ46944299-275B0D66-0D18-4C44-990B-3F7E923444A5Q48176377-5E49831F-4005-4C62-87D3-36452E032C65Q49990263-7D3C3371-321D-4981-9E5B-4746CE3D6986Q57776797-5F093665-6759-4E4E-AB49-F8171A5C10C5
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Mycolactones and Mycobacterium ulcerans disease.
@ast
Mycolactones and Mycobacterium ulcerans disease.
@en
Mycolactones and Mycobacterium ulcerans disease.
@nl
type
label
Mycolactones and Mycobacterium ulcerans disease.
@ast
Mycolactones and Mycobacterium ulcerans disease.
@en
Mycolactones and Mycobacterium ulcerans disease.
@nl
prefLabel
Mycolactones and Mycobacterium ulcerans disease.
@ast
Mycolactones and Mycobacterium ulcerans disease.
@en
Mycolactones and Mycobacterium ulcerans disease.
@nl
P2093
P1433
P1476
Mycolactones and Mycobacterium ulcerans disease.
@en
P2093
Pamela L Small
Winette T A van der Graaf
Ymkje Stienstra
P304
P356
10.1016/S0140-6736(03)14417-0
P407
P577
2003-09-01T00:00:00Z